Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0528-2019Class II

BD BBL Trypticase Soy Agar with 5% Sheep Blood, Catalog No. 221261, (non-selective, non-differential)

Becton Dickinson & Co / initiated 2018-10-22 / Terminated / root cause: manufacturing process

Becton Dickinson & Co. began a recall of BD BBL Trypticase Soy Agar with 5% Sheep Blood, Catalog No. 221261, (non-selective, non-differential) on . FDA classified it as Class II and gives the reason as "a portion of a single lot was not manufactured in accordance with the internal formulation resulting in inhibited growth of Gram negative organisms". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0528-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Becton Dickinson & Co
Product
BD BBL Trypticase Soy Agar with 5% Sheep Blood, Catalog No. 221261, (non-selective, non-differential)
Product code
JSG Culture Media, Non-Selective And Non-Differential
Reason for recall
a portion of a single lot was not manufactured in accordance with the internal formulation resulting in inhibited growth of Gram negative organisms.
Root cause tag
manufacturing process
FDA root cause
Mixed-up of materials/components
Action
Distributors were notified via email on October 22, 2018, requesting their customer distribution list. Customer letters were sent via UPS beginning on October 29, 2018. **Distributors are Advised to do the following: 1.Discard any remaining inventory of the above referenced product. 2.Complete the attached Distributor Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification and process your product replacement. 3.Within three days, provide an Excel file or a list with name, address and telephone number of end-users who were shipped this product from your distribution branches so we may inform them of this issue. Fax or email to: BD Regulatory Compliance Fax: 410-316-4258 Email: [email protected] 4.A copy of the customer communication is attached for your records. **Customers area Advised to Take the Following Action(s): 1. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification. 2. Discard any remaining inventory of lot 8221508. BD will process replacement of any discarded inventory upon receipt of the Customer Response Form. 3. Share a copy of the Recall Letter with all users of the product within your facility to ensure awareness. Customers with questions may call 800-638-8663, Monday through Friday 7 am - 7 pm, EST.
Quantity in commerce
54,300 plates
Distribution
US Nationwide distribution in the states of AL, AR, AZ, CA, CT, FL, GA, HI, MA, MD, MI, MN, NC, NH, NJ, NY, OH, OK, PA, RI, TX, VA, VT, WA, WV
Product codes and lots
UDI - (01)10382902212611(17)181130  (10)8221508  Lot No.: 8221508  Expiration Date: 2018-11-30

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0528-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0528-2019Class IITerminatedVoluntary: Firm initiated